about
Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses.Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivoCD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.Critical and direct involvement of the CD23 stalk region in IgE binding.Recombinant allergen-based provocation testing.Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay.Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layersBasophils are not the key antigen-presenting cells in allergic patientsSafety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells.Molecular Aspects of Allergens and Allergy.Omalizumab's Impact on Total and Allergen-Specific IgE Levels: A Polyclonal Story.Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function.Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23.Characterisation of recombinant CD23 in the trimeric complex with IgE and allergenAllergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses[Medical news reports in daily papers--a case example (quantitative analysis, categorization of contents, qualitative analysis of report on "vaccination")]BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formationExposure of rye (Secale cereale) cultivars to elevated ozone levels increases the allergen content in pollenEditorial: natural killer cell-mediated augmentation of autoantibody production?Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier FunctionAssociations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory DiseaseAllergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activationTwo years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 responseTracing IgE-Producing Cells in Allergic Patients
P50
Q33880127-51DD4AAB-558C-466D-B79C-A5738B07CEEFQ34508199-538DD8ED-F0E1-4249-8011-E37F5871CE17Q35566610-24F1AF78-D170-4E99-8DCE-2662C86CDE0DQ36751511-F71F223B-21BF-4A00-AAFE-4091A9AB659EQ37660379-E443813C-7715-41D5-948B-9E7C59691092Q37660384-365E6F2D-4AC2-496F-B21A-B4725B66E9B2Q38127011-5FCAE24D-0464-4AE2-A13D-AB5A1A829026Q38921495-F1B773F5-A062-423C-9850-18ED8F4C8B90Q41761697-32610805-5C34-43B7-8886-09D791C7A2D7Q42429037-06EFD9AA-F277-48AE-A99E-AB9009349F1FQ42591766-855D0CFC-13C0-4561-B045-ABC8FF7BCD46Q47649812-435CF1A4-3AE7-4B46-9EB2-598F0257AD3AQ48104072-2CA95B45-FE70-478F-81D5-123521CEBB05Q50941015-E1F1BEEB-628F-463F-9C89-331C50C33F76Q53825271-89FC981C-2666-4FF6-8902-59FA38339AF0Q54153454-A3485CC9-5B39-4F02-8756-54304F0203AEQ55512190-E18793BF-89E1-483F-988F-403FEF1BFB92Q55630218-403C14DD-AA30-4E35-AF2B-92D75E7EBE43Q59412401-D3D4B951-17CD-466B-97D7-A1D62E9D27A4Q61814280-45BE2D4A-64C3-40EE-A628-BCB15B1FE77FQ74807380-B45EBA54-37C1-4BF6-AEF0-CFDB42B82E5EQ83187970-82AE47EF-2130-4417-BA22-A9ABB63D1E20Q84626244-9D3951A6-D3DC-4992-A069-1E2437ED492AQ87400285-85272279-F901-4B49-8B11-45EED1B843CAQ89491207-4DF22228-DC94-4E98-9E18-F9C30139AD15Q90775075-C6BB6318-3BF8-43C3-B535-6F8A83600205Q91489469-0E23FE4B-1D33-451B-B270-5ED35C6DE9FEQ91570581-43DE96E5-14D5-4089-A260-9DBC07D0872BQ92988172-85E31F14-2FB7-4DDA-BDFF-1C86DC96F10A
P50
description
researcher
@en
name
Eckl-Dorna J
@nl
Julia Eckl-Dorna
@en
type
label
Eckl-Dorna J
@nl
Julia Eckl-Dorna
@en
altLabel
Eckl-Dorna J
@en
prefLabel
Eckl-Dorna J
@nl
Julia Eckl-Dorna
@en
P106
P31
P496
0000-0001-5981-1607